Teladoc Health Inc.

TDOC | NYSE

Price Alert Chart Builder DCF Calculator

$6.24

-$0.03 (-0.48%)

Sep 22, 2026, 12:28 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.14B

Enterprise Value $1.39B

Beta 2.13

Average Volume 4.8M

Shares Outstanding (Diluted) 180.08M

Shares Change YoY 2.37%

Institutional Ownership 80.08%

Exchange NYSE

ISIN US87918A1051

Price Performance

Price Change 1M -1.6%

Price Change 3M -18.5%

Price Change 6M 12.6%

Price Change YTD -11.1%

Price Change 1Y -23.4%

Price Change 3Y -66.6%

Price Change 5Y -95.3%

1M CAGR (ann.) -12.1%

1Y CAGR (ann.) -24.1%

5Y CAGR (ann.) -46.2%

All-Time CAGR -9.4%

Valuation

PE Ratio -6.33

Forward PE N/A

PEG Ratio -0.38

Forward PEG 0.23

PS Ratio 0.46

Forward PS 0.50

PB Ratio 0.87

P/FCF Ratio 5.07

P/Adj. FCF Ratio 6.43

P/OCF Ratio 4.32

EV/Sales 0.56

EV/EBIT -8.68

EV/EBITDA -19.90

EV/FCF 6.19

Earnings Yield -15.8%

FCF Yield 19.7%

Adj. FCF Yield 15.6%

Financial Health

Net Debt $222.35M

Total Debt $1.03B

Cash & Short-Term Investments $774.35M

Total Assets $2.76B

Current Ratio 0.83

Quick Ratio 0.81

Debt / Equity Ratio 0.79

Debt / EBITDA -14.68

Debt / FCF 4.57

OCF / Debt 0.25

Interest Coverage -8.71

Altman Z-Score -7.31

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 73.5%

Operating Profit Margin -7.0%

EBITDA Margin -2.8%

Net Profit Margin -7.1%

FCF Margin 9.0%

Adj. FCF Margin 7.1%

SBC / Revenue 1.9%

SBC Impact (per share) -21.1%

Returns

Return on Assets -6.4%

Return on Equity -13.1%

Return on Invested Capital -7.1%

Return on Capital Employed -12.6%

Return on Tangible Assets -13.7%

Historical Growth (CAGR)

Revenue CAGR 3Y -0.6%

Revenue CAGR 5Y 8.8%

Revenue CAGR 10Y 38.5%

EPS CAGR 3Y 91.4%

EPS CAGR 5Y 76.6%

EPS CAGR 10Y -7.8%

FCF CAGR 3Y -0.6%

FCF CAGR 5Y 0.5%

FCF CAGR 10Y 36.6%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 42

EPS Growth Next 3Y 24.9%

Revenue Growth Next 3Y -0.8%

Earnings Date Oct 27, 2026

EPS Estimate (next Q) -$0.23

EPS Growth Est (next Q) -17.9%

Revenue Est (next Q) $590.3M

Revenue Growth Est (next Q) -5.8%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $8.83

Price Target Upside 40.8%

Cash Flow

Operating Cash Flow $261.18M

Free Cash Flow $224.66M

Adj. Free Cash Flow $177.14M

FCF Per Share $1.25

OCF Per Share $1.45

OCF/S Ratio 10.5%

Income Statement

Revenue $2.49B

Gross Profit $1.83B

Operating Income $-173.78M

EBITDA $-69.89M

Net Income $-177.4M

EPS (Diluted) -$0.99

Revenue / Employee $485.85K

Profit / Employee $-34.62K

Employees 5,124